Novavax, Inc. is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. More...
Novavax, Inc. (Nasdaq: NVAX) is headquartered in Gaithersburg, Maryland with additional facilities in Rockville, Maryland and Uppsala, Sweden, and employs over 300 individuals dedicated to developing novel vaccines to address infectious disease. Our product pipeline targets a variety of infectious diseases with vaccine candidates currently in clinical development for respiratory syncytial virus (RSV), seasonal and pandemic influenza and Ebola virus. More...
In the News
Careers at Novavax
Are you ready to work for one of Washington's Top Workplaces? We welcome your interest in joining our team and creating tomorrow’s vaccines. Novavax is a fast-paced company that provides employees with opportunities for professional growth, as well as the flexibility to achieve a balance between work and personal life. We invite you to apply for our open positions.
Click here to see a list of open positions.